DCA at DDL 2023

Published on: 29th November 2023

DCA is sponsoring and exhibiting at this year’s Drug Delivery to the Lungs conference (DDL2023) on 6th to 8th December 2023 at the Edinburgh International Conference Centre, Scotland.

Widely recognised as the premier international conference and exhibition dedicated to pulmonary and nasal drug delivery, DDL2023 offers a rich three-day scientific lecture programme, an array of carefully selected keynote presentations, a poster exhibition and industry exhibitor demonstrations. Now in its 34th year, DDL attracts more than 1000 attendees from around the world.

We look forward to seeing you there!

If you are planning to attend, we’d love to see you at our stand (#158) to catch up and to discuss how our exceptional, multi-disciplinary development team can support your device projects.

If you would like to arrange a specific time to meet, please contact [email protected]

With a wealth of experience gained developing leading originator drug delivery devices for global markets as well as generic devices, DCA’s work includes:

  • Dry powder inhalers for asthma, COPD and inhaled insulin
  • Pressurised metered dose inhalers
  • Breath actuated inhalers
  • Intranasal delivery devices
  • Dose counters and indicators
  • Regimen assistance/assurance devices
  • Connected and electro-mechanical devices
  • Design for sustainability
  • Due diligence and device selection
Our portfolio encompasses mass-market drug delivery devices that are manufactured in multi-billions, as well as lower volume devices targeting specific user populations and regional market needs. Alongside device design, we provide comprehensive support for industrialisation and create innovative instructions and product packaging solutions.

Please visit our virtual exhibition for DDL

Join us at stand #158